StonvexLoading…
StonvexStonvexStonvexCore line items from DSX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $213.54M | $228.21M | $262.10M | $289.97M |
Operating Income | $42.19M | $58.78M | $85.71M | $142.70M |
Net Income | $17.83M | $12.75M | $49.84M | $119.06M |
EPS (Diluted) | $0.11 | $0.05 | $0.42 | $1.36 |
Total Assets | $1.17B | $1.17B | $1.17B | $1.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $50.51M | $124.67M | $101.59M | $76.43M |
Free Cash Flow OCF − CapEx | Not available | Not available | $40.65M | $-71.44M |
Shares Outstanding | 115.79M | 125.20M | 113.07M | 102.65M |